950160.KQ
Price:
$20750
Market Cap:
$1.76T
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Industry
Biotechnology
IPO Date
2017-11-06
Stock Exchange
KOE
Ticker
950160.KQ
According to Kolon TissueGene, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.75T. This represents a change of -74.18% compared to the average of 6.79T of the last 4 quarters.
The mean historical Enterprise Value of Kolon TissueGene, Inc. over the last ten years is 1.67T. The current 1.75T Enterprise Value has changed 10.41% with respect to the historical average. Over the past ten years (40 quarters), 950160.KQ's Enterprise Value was at its highest in in the March 2026 quarter at 8.86T. The Enterprise Value was at its lowest in in the December 2022 quarter at 530.42B.
Average
1.67T
Median
655.25B
Minimum
486.05B
Maximum
6.50T
Discovering the peaks and valleys of Kolon TissueGene, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 270.36%
Maximum Annual Enterprise Value = 6.50T
Minimum Annual Increase = -55.60%
Minimum Annual Enterprise Value = 486.05B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.50T | 270.36% |
| 2024 | 1.75T | 167.77% |
| 2023 | 655.25B | 18.53% |
| 2022 | 552.81B | -55.60% |
| 2021 | 1.25T | 156.17% |
| 2020 | 486.05B | -0.68% |
The current Enterprise Value of Kolon TissueGene, Inc. (950160.KQ) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.97T
5-year avg
2.14T
10-year avg
1.67T
Kolon TissueGene, Inc.’s Enterprise Value is less than SK bioscience Co.,Ltd. (3.28T), less than Hugel, Inc. (2.42T), less than Voronoi, Inc. (2.80T), less than HLB Co., Ltd. (5.41T), less than D&D Pharmatech (2.44T), less than LigaChem Biosciences Inc. (3.56T), less than PharmaResearch Co., Ltd. (4.16T), less than OliX Pharmaceuticals,Inc (1.90T), greater than GI Innovation, Inc. (462.82B), greater than Chabiotech Co.,Ltd. (1.27T),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.28T | $2.86T | |
| 2.42T | $2.65T | |
| 2.80T | $2.79T | |
| 5.41T | $5.14T | |
| 2.44T | $2.33T | |
| 3.56T | $3.64T | |
| 4.16T | $4.16T | |
| 1.90T | $1.99T | |
| 462.82B | $490.06B | |
| 1.27T | $760.37B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kolon TissueGene, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kolon TissueGene, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kolon TissueGene, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kolon TissueGene, Inc. (950160.KQ)?
What is the 3-year average Enterprise Value for Kolon TissueGene, Inc. (950160.KQ)?
What is the 5-year average Enterprise Value for Kolon TissueGene, Inc. (950160.KQ)?
How does the current Enterprise Value for Kolon TissueGene, Inc. (950160.KQ) compare to its historical average?